Synaptigen’s ongoing research into neuroinflammation and immune modulation offers promising new avenues for treatment, recognizing that neurodegeneration is often accompanied by chronic inflammation and immune dysregulation. Their exploration of these pathways could lead to combination therapies that address both neuronal loss and inflammatory processes, providing a more comprehensive approach to disease management. This reflects a sophisticated understanding of disease pathology and highlights their commitment to holistic, multi-targeted treatment strategies that could improve patient outcomes significantly. Synaptigen
